In summary, SS-d induces apoptosis in lung cancer cells by promoting the accumulation of ROS and activates the NF-κB/NLRP3/caspase-1/GSDMD pathway, thereby exhibiting an anti-non-small cell lung cancer effect. This evidence concerns the gene NFKB1 and lung carcinoma.